Cogent Biosciences, Inc. (COGT)
35.00
+0.33
(+0.95%)
USD |
NASDAQ |
Aug 31, 16:00
35.26
+0.26
(+0.74%)
After-Hours: 18:41
Cogent Biosciences Cash from Operations (Annual) : -264.44M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -264.44M |
| December 31, 2024 | -207.79M |
| December 31, 2023 | -153.62M |
| December 31, 2022 | -118.64M |
| December 31, 2021 | -58.76M |
| December 31, 2020 | -35.85M |
| Date | Value |
|---|---|
| December 31, 2019 | -41.51M |
| December 31, 2018 | -32.49M |
| December 31, 2017 | -25.84M |
| December 31, 2016 | -18.64M |
| December 31, 2015 | 17.72M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Apogee Therapeutics, Inc. | -227.45M |
| Erasca, Inc. | -95.46M |
| Moderna, Inc. | -1.873B |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |